av/vaxcyte--big.svg

NASDAQ:PCVX

Vaxcyte

  • Stock

35.24

−1.67%

0.56

USD last updated 30/07 01:56:25

Last Close

34.68

29/07 20:04

Market Cap

8.81B

Beta: 0.96

Volume Today

3.82M

Avg: 962.38K

PE Ratio

−25.01

PFCF: −32.24

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect ag...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -2-1.5-1-0.52019-03-302020-03-312021-08-112023-08-082024-08-13

    Revenue (Estimate*)

    0.000.000.010.010.012019-03-302020-03-312021-08-112023-08-082024-08-13

    *Estimate based on analyst consensus